PALI Competitors & Alternatives
Compare Palisade Bio Inc with similar stocks in the same industry
Biotechnology
PALI
Main Stock$1.89
Tradestie Score
52
Market Cap
$12.21M
P/E Ratio
16.3
Analyst Upside
+455.6%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.18
|
$371.64M | - | 63 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$20.61
|
$357.51M | - | 44 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.87
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$32.25
|
$353.70M | - | 63 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.61
|
$350.98M | - | 55 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.99
|
$341.56M | - | 62 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.63
|
$332.96M | - | 60 | Compare |
|
REPL
Replimune Group, Inc.
|
$9.94
|
$328.62M | - | 57 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.16
|
$319.22M | - | 56 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.62
|
$308.74M | - | 60 | Compare |
More PALI Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry